课题基金 / 基金详情

Amine N-Oxygenation by FMO3 and FMO4

Amine N-Oxygenation by FMO3 and FMO4
FMO3 和 FMO4 的胺氮氧化
批准号:
6874304
负责人:
John R Cashman
金额:
$37.44万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-04-15 至 2009-02-28

项目摘要

项目成果

John R Cashman的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Variation in neurotransmitter transporters, receptors and abnormal levels of neurotransmitters potentially are involved in neurological diseases including schizophrenia, bipolar affective disorder, autism, affective disorder, late onset Alzheimer's disease, Parkinson's disease and others. Fundamental information characterizing human neurotransmitter metabolism associated with neurodegenerative diseases could provide new approaches to understanding the pathology and developing new therapeutics. Our central hypothesis is that lack of detoxication of endogenous or xenobiotic amines underlies the pathological condition of some CNS diseases. The human flavin-containing monooxygenase (FMO) is one of the major human enzyme systems that contribute to the detoxication of endogenous, environmental and dietary nitrogen-containing substances. The overall goal of our work is to understand the details of FMO-mediated N-oxygenation of amines and hydroxylamines. Accumulation of hydroxylamines in the CNS may lead to cytotoxicity or apoptosis. To test this, fundamental information about human brain FMO N-oxygenation is required. The overall goal will be accomplished by addressing five Specific Aims including: Aim 1: cDNA-express the major forms of human brain FMO; Aim 2: Chemically synthesize amine metabolites of human brain FMO; Aim 3: Determine the kinetics and mechanism of human brain FMO amine N-oxygenation; Aim 4: Test the effects of human brain FMO amine metabolites on neuronal cell function including cytotoxicity and apoptosis, and Aim 5: Investigate the mechanism of amine metabolites on human neurotransmitter function. The significance is that fundamental biochemical information will result in new insight about the way endogenous and xenobiotic and dietary amines are metabolized in human brain. Such fundamental information will be useful in the development of safer drugs, the prevention of adverse drug reactions and the protection of humans from disease.
期刊论文(23)
专著(0)
科研奖励(0)
会议论文
Effect of genetic variants of the human flavin-containing monooxygenase 3 on N- and S-oxygenation activities.
人含黄素单加氧酶 3 的遗传变异对 N-和 S-氧化活性的影响。
DOI: --
发表时间: 2007
期刊: Drug Metab Dispos. 35(3)
影响因子: --
作者: [Shimizu, M. et al., Shimizu M. et al., Yamazaki H. et al., Shimizu M. et al.]
通讯作者: Shimizu M. et al.
DOI: 10.1016/j.ymgme.2009.02.006
发表时间: 2009-06
期刊: MOLECULAR GENETICS AND METABOLISM
影响因子: 3.8
作者: [Motika, Meike S., Zhang, Jun, Zheng, Xueying, Riedler, Kiersten, Cashman, John R.]
通讯作者: Cashman, John R.
The role of flavin-containing monooxygenases in drug metabolism and development.
含黄素单加氧酶在药物代谢和开发中的作用。
DOI: --
发表时间: 2003
期刊: Current opinion in drug discovery & development.
影响因子: --
作者: [Cashman,JohnR]
通讯作者: Cashman,JohnR
Hepatic flavin-containing monooxygenase gene regulation in different mouse inflammation models.
不同小鼠炎症模型中肝脏含黄素单加氧酶基因的调控。
DOI: 10.1124/dmd.108.025338
发表时间: 2009
期刊: Drug metabolism and disposition: the biological fate of chemicals
影响因子: --
作者: [Zhang,Jun, Chaluvadi,MadhusudanaR, Reddy,Rob, Motika,MeikeS, Richardson,TerrilynA, Cashman,JohnR, Morgan,EdwardT]
通讯作者: Morgan,EdwardT
11
    Novel Small Molecule Therapeutics for Pancreatic Cancer
    • 批准号:
      8647088
    • 项目类别:
    • 资助金额:
      $24.06万
    • 财政年份:
      2014
    • 负责人:
      John R Cashman
    • 依托单位:
    Small Molecule Toolbox: Cardiomyocytes from Human Stem Cells
    • 批准号:
      8125859
    • 项目类别:
    • 资助金额:
      $17.21万
    • 财政年份:
      2011
    • 负责人:
      John R Cashman
    • 依托单位:
    Novel Medicinal Chemicals: Cardiomyogenesis from Human Stem Cells
    • 批准号:
      8058646
    • 项目类别:
    • 资助金额:
      $17.25万
    • 财政年份:
      2011
    • 负责人:
      John R Cashman
    • 依托单位:
    Biosensor for real-time chemical monitoring
    国内基金
    海外基金
    Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
    • 批准号:
      LBY21H010001
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2020
    • 负责人:
      郑绪阳
    • 依托单位:
    去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
    • 批准号:
      31970691
    • 项目类别:
      面上项目
    • 资助金额:
      58.0万元
    • 批准年份:
      2019
    • 负责人:
      张胜萍
    • 依托单位:
    TM9SF4调控非小细胞肺癌细胞凋亡机制研究
    • 批准号:
      31900527
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      24.0万元
    • 批准年份:
      2019
    • 负责人:
      孙磊
    • 依托单位:
    基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
    • 批准号:
      81703335
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      20.0万元
    • 批准年份:
      2017
    • 负责人:
      卫高菲
    • 依托单位: